On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

StockGuru Blog: Lotus (OTCBB: LTUS) Delivers Prescription Medication in Great Demand

Lotus Delivers Prescription Medication in Great Demand

Lotus Pharmaceuticals, Inc. (OTCBB: LTUS)

Lotus Pharmaceuticals has a myriad of drugs ready for market deployment with Chinese FDA approval. Pharmaceuticals continue to be the largest and most profitable business for Lotus. Cardiovascular drugs including VALSARTAN which is used to control hypertension is a commonly prescribed drug in China.

These are identified below:

Gatifloxacin Lactate Injection
Indications of the two types of drugs are as follows: acute nasosinusitis caused by the treatment of sensitive bacteria, acute outbreaks of the chronic bronchitis, pneumonia attained in a community, simple or complex cystitis, nephritis of renal pelvis, simple urethra and cervix gonorrhea, acute simple-natured rectal infection of women

Calcium Dibutyryl Adenosine Monophosphate for Injection
This medicine is for the treatment of angina and acute myocardial infarction. It is a ramification of the chemosuythesized dibutyryl adenosine and a type of activator on albumen. Its osmosis is stronger than that of dibutyryl adenosine and it is able to confront the reducing and dispelling effects of PDE. So it has a fast and enduring effect on reducing the oxygen shortage of cardiac muscles, dilating coronary artery, boost up the contractibility of cardiac muscles and increasing the flow of blood from the heart.
Nicergoline for Infection (spec: 4mg)

Used for the treatment of poor conation and sensibility obstacles caused by naogengse sequela, such as hypoesthesia, poor concentration, memory recession, idea shortage and anxiety. It is a ramification of the half- synthetically ergot and can blocks the receptors and dilate bloods vessels. Therefore, it is able to strengthen the metabolism of brain cells and make better use of oxygen and dextrose, thus improve the working of the brain.

Soduim Aescinate for Injection (spec: 5mg, 10mg)
This medicine is used for used for the treatment of hydrocephalus caused by different diseases, tumefaction arising of wounds and operations, as well as circumfluence expediency of the vein. As a type of anti-tumefaction and inflammation-diminishing drug, it has effects such as anti-effusion, increasing vein tensility, anti-tumefaction, anti- inflammation, and improving blood circulation.

Rabeprazole Sodium, Rabeprazole Sodium Entericoated Tablet (spec: 10mg)
This medicine is used for the treated of gastric ulcer, duodenum ulcer, anastomosis ulcer, anti-flow of esophagus inflammation, Zollinger- Ellison syndrome.

Compound Allantoin Dispersible Tablets (spec: 12pill/plate)
It is used for the treatment of gastric ulcer, ulcer of the ball part of the duodenum and chronic gastritis.

Candesartan Pills (spec: 8mg)
It is used for the treatment of primary hypertension of light and medium levels. As AT1 CB of Angell receptors, it works through selectively blocking the combination between Angell, adrenal gland and vascular uterine cells thus restraining the shrinkage of blood vessels and excretion of aldosterone to reduce the blood pressure. (It is a patented product of our Company.)

Nicergoline Pills (spec: 10mg)
It is used for the treatment of poor conation and sensibility obstacles caused by naogenges sequela, such as hypoesthesia, poor concentration, memory recession, idea shortage and anxiety. It is a ramification of the half-synthetically ergot and can block the receptors and dilate blood vessels. Therefore, it is able to strengthen the metabolism of brain cells and make better use of oxygen and dextrose, thus improve the working of the brain. (It is a patented product of our Company.)

Rabeprazole Sodium Pills (spec: 10mg)
This medicine is used for the treatment of gastric ulcer, duodenum ulcer, anastomosis ulcer, anti-flow of esophagus inflammation, Zollinger-Ellison syndrome.

There are four divisions of Lotus which handle scientific research on new medicine, the production, wholesale and retail of medicine to treat chronic myeloid leukemia. With a total of twelve projects in clinical development, Lotus has a broad and innovative and pipeline.

Source: Lotus Pharmaceuticals

View the StockGuru Profile for Lotus Pharmaceuticals:

http://www.stockguru.com/profiles/ltus/

We Invite you to Visit the All New StockGuru Blog!

Here you will find updates on all our covered companies, including Profiled Companies and StockGuru Picks.

Click HERE to visit the Blog, or go to:

http://stockguru.com/blog/

StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (469) 252-3030. Web: StockGuru.com. Email: Publisher@stockguru.com. Disclosure: Pentony Enterprises LLC was compensated $10,000 directly from the company for profile coverage. Pentony Enterprises LLC is not a registered investment adviser or broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site aresuitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.

Archives

Select A Month
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009
  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008
  • February 2008
  • January 2008
  • December 2007
  • November 2007
  • October 2007
  • September 2007
  • August 2007
  • July 2007
  • June 2007
  • May 2007
  • April 2007
  • March 2007
  • February 2007
  • January 2007
  • December 2006
  • November 2006
  • October 2006
  • September 2006
  • August 2006
  • July 2006
  • June 2006
  • May 2006
  • April 2006
  • March 2006
  • January 2006
  • December 2005
  • October 2005
  • September 2005
  • Market Basics

    New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

    The Basics

    Newsletter Publishers

    Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

    Register

    Public Companies

    Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

    Get Covered